Literature DB >> 10363977

Competitive and noncompetitive inhibition of the DNA-dependent protein kinase.

R A Izzard1, S P Jackson, G C Smith.   

Abstract

The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase that is involved in mammalian DNA double-strand break repair. The catalytic subunit of DNA-PK (DNA-PKcs) shares sequence homology in its kinase domain with phosphatidylinositol (PI) 3-kinase. Here, we provide a detailed kinetic analysis of DNA-PK inhibition by the PI 3-kinase inhibitor wortmannin and demonstrate this inhibition to be of a noncompetitive nature, with a Ki of 120 nM. Another inhibitor of PI 3-kinase. LY294002, its parent compound, quercetin, and other derivatives have also been studied. These chemicals are competitive inhibitors of DNA-PK, with LY294002 having a Ki of 6.0 microM. Using an antibody to wortmannin, we found that this compound binds covalently to the kinase domain of DNA-PKcs both in vitro and in vivo. Binding of wortmannin to the active site of DNA-PKcs is inhibited by ATP but not by a peptide substrate. Furthermore, wortmannin is able to bind to DNA-PKcs independently of Ku, and it is not stimulated by the presence of DNA. This suggests that the ATP binding site of DNA-PKcs is open constitutively and that DNA activation of the kinase is mediated via another mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363977

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM.

Authors:  G C Smith; R B Cary; N D Lakin; B C Hann; S H Teo; D J Chen; S P Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells.

Authors:  A Danilkovitch; S Donley; A Skeel; E J Leonard
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells.

Authors:  D Kültz; D Chakravarty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Synapsis of DNA ends by DNA-dependent protein kinase.

Authors:  Lisa G DeFazio; Rachel M Stansel; Jack D Griffith; Gilbert Chu
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

5.  Intrahippocampal wortmannin infusion enhances long-term spatial and contextual memories.

Authors:  Pramod K Dash; Sara A Mach; Sonja Blum; Anthony N Moore
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

6.  Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.

Authors:  Xiaoshan Zhang; Janice Succi; Zhaohui Feng; Sheela Prithivirajsingh; Michael D Story; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Activity of any class IA PI3K isoform can sustain cell proliferation and survival.

Authors:  Lazaros C Foukas; Inma M Berenjeno; Alexander Gray; Asim Khwaja; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

8.  Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.

Authors:  Liyi Geng; Xiaoshan Zhang; Shu Zheng; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

9.  The N-terminal region of the DNA-dependent protein kinase catalytic subunit is required for its DNA double-stranded break-mediated activation.

Authors:  Anthony J Davis; Kyung-Jong Lee; David J Chen
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

10.  Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.

Authors:  P O Carminati; F S Donaires; M M Marques; E A Donadi; G A S Passos; E T Sakamoto-Hojo
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.